Endurant Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-53,247
| Closed | -$2.58M | – | 49 |
|
|
2023
Q1 | $2.58M | Buy |
53,247
+35,361
| +198% | +$1.71M | 1.32% | 21 |
|
|
2022
Q4 | $683K | Buy |
+17,886
| New | +$683K | 0.28% | 42 |
|
|
2020
Q3 | – | Sell |
-19,677
| Closed | -$998K | – | 69 |
|
|
2020
Q2 | $998K | Buy |
+19,677
| New | +$998K | 0.05% | 47 |
|
|
2019
Q2 | – | Sell |
-16,903
| Closed | -$636K | – | 71 |
|
|
2019
Q1 | $636K | Buy |
+16,903
| New | +$636K | 0.25% | 53 |
|
|
2016
Q1 | – | Sell |
-14,800
| Closed | -$480K | – | 89 |
|
|
2015
Q4 | $480K | Sell |
14,800
-8,200
| -36% | -$266K | 0.16% | 70 |
|
|
2015
Q3 | $614K | Sell |
23,000
-1,100
| -5% | -$29.4K | 0.21% | 65 |
|
|
2015
Q2 | $1.16M | Buy |
+24,100
| New | +$1.16M | 0.34% | 61 |
|